skip navigation
NIH Record  
Vol. LXIV, No. 17
  August 17, 2012
Collins Discusses Biology of Aging at Interest Group Meeting
Freire To Return to Area to Head FNIH
NIH Safety, Health and Wellness Day,
Aug. 29 at Natcher
Bushnell Named Director of New NCCAM Program on Pain, Brain
PECASE Honors Three from Intramural NIH
NIH Officers Deployed for July 4 Celebration in D.C.
printer friendly version
Office of the Director Hosts All-Hands Meeting

NIH principal deputy director Dr. Lawrence Tabak addresses OD all-hands meeting.

NIH principal deputy director Dr. Lawrence Tabak addresses OD all-hands meeting.

On July 16, Office of the Director employees gathered at an all-hands meeting to hear NIH leadership thank them for their hard work, describe challenges and accomplishments and relay results of a recent employee survey.

To a full Masur Auditorium, Dr. Lawrence Tabak, NIH principal deputy director, joked, “The rumor is that I’m going to retire and that this was the only way I could get anyone to come to the party.” He urged everyone to “Exhale! Nothing bad is going to happen…Thank you, first and foremost. Without you, very important things would not get done around here.”

Tabak introduced the five other NIH deputy directors, allowing each to outline his or her responsibilities and share recent accomplishments and challenges.

Dr. James Anderson, director of the Division of Program Coordination, Planning and Strategic Initiatives, explained the divisionís role of overseeing research infrastructure, advancing comparison medicine and identifying scientific priorities across NIH.

Can We Be Clear?
Spiegelhalter Explores Ways to Convey Health Risks, Benefits

Would you be willing to forego your daily burger for the possibility of living a little longer? Would you tolerate some heartburn for the possible benefits of a statin? People make decisions about the risks and benefits of treatments and behaviors every day. But are they making them based on solid information and understanding?

In his recent lecture, “Communicating Possible Harms and Benefits of Treatment and Lifestyle,” Prof. David Spiegelhalter argued that researchers and clinicians need a broad array of tools if they are going to improve public understanding of health-related research.

“There is an ethical need to communicate harms and benefits in a transparent way,” said Spiegelhalter, who is Winton professor of the public understanding of risk at the University of Cambridge in the United Kingdom. "We have an obligation to do that if you believe in shared care and informed decision-making.”